Similar articles

• [How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections?].

  Boissonnas A. Boissonnas A. Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:54-5. Ann Med Interne (Paris). 1994. PMID: 7880021 French. No abstract available.
• [Treatment of drug addicts with methadone in medical practice-- problems of the treatment of heroin addicts with methadone in view of the HIV epidemic].

  Fuchs WJ. Fuchs WJ. Schweiz Rundsch Med Prax. 1988 Mar 29;77(13):354-7. Schweiz Rundsch Med Prax. 1988. PMID: 3375659 German. No abstract available.
• [How would the development of substitution treatments modify the care of drug addicts?].

  Charles-Nicolas A. Charles-Nicolas A. Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:79-81. Ann Med Interne (Paris). 1994. PMID: 7880033 French. No abstract available.
• Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.

  Sullivan LE, Fiellin DA. Sullivan LE, et al. Clin Infect Dis. 2005 Sep 15;41(6):891-6. doi: 10.1086/432888. Epub 2005 Aug 10. Clin Infect Dis. 2005. PMID: 16107991 Review.
• [Opiate replacement therapy in France: assessment of the public policies].

  Chast F. Chast F. Ann Pharm Fr. 2009 Sep;67(5):299-303. doi: 10.1016/j.pharma.2009.06.006. Epub 2009 Jul 30. Ann Pharm Fr. 2009. PMID: 19695365 Review. French. No abstract available.